Enhancing the Feasibility of Large Cohort Studies
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The identification of many hundreds of genetic variants associated with complex diseases and their potential for interactions with environmental factors have increased the need for prospective cohort studies involving several hundred thousand participants. [1,2]. Costs of such studies under conventional funding models are high because typically they are conducted by consortia of academic centers each responsible for recruitment, examination, and follow-up of a subcohort of participants in its geographic area [3,4]. The costs and inefficiencies in 100-fold expansion of these standard models can be prohibitive; large studies should not be viewed simply as small studies made large. Rather, they require fundamentally different approaches in which minimizing cost is a primary consideration, and “process” proficiency to maximize efficiency is as important as scientific expertise. UK Biobank is a large prospective study that relies on a centralized strategy for nearly all aspects of its conduct. (5) This strategy, which UK Biobank adopted after rejecting a decentralized approach due to excessive cost, has achieved exceptional efficiencies while retaining scientific rigor. The main phase of recruitment started in April 2007 after a successful integrated pilot of the recruitment and assessment processes. The recruitment target of 500,000 individuals aged 40-69 years was achieved in July 2010, about 18 months ahead of schedule and within budget. (5) The UK Medical Research Council and Wellcome Trust charity are the chief funders (5), and the total cost of recruitment and baseline assessments, along with establishing the sample and data storage infrastructure, was about $100M. Annual costs for the subsequent phase of health outcome follow-up and adjudication, as well as maintaining the sample store and developing the IT systems to facilitate use by researchers, are estimated to be about $7M. The success of the UK Biobank model may provide valuable lessons for the efficient operation of large prospective studies in the US.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652 · cited 1×
“Costs of such studies under conventional funding models are high because typically they are conducted by a consortia of academic centers, each responsible for recruitment, examination, and follow-up of a subcohort of participants in its geographic area.(3,4) The costs and inefficiencies in 100-fold expansion of these…”
BackgroundSelf-citationMortality from cancer in relation to smoking: 50 years observations on British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602359 · Cited by 392
Cited by
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728
“The key lessons learned from establishing UK Biobank are that such large-scale studies require not only a clear scientific focus but also streamlined governance; effective working between academic and management disciplines; centralised infrastructure with industrial approaches to collection and processing of data and…”
BackgroundSelf-citationWhat makes UK Biobank special?
Collins, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60404-8 · Cited by 1,128
Self-citationChen, Z., Chen, J., Collins, R., Guo, Y., Peto, R., Wu, F., Li, L., & on behalf of the China Kadoorie Biobank (CKB) collaborative group (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr120 · Cited by 1,034
Self-citationCharting a course for genomic medicine from base pairs to bedside
National Human Genome Research Institute, Green, E. D., & Guyer, M. S. (2011) · Nature · doi:10.1038/nature09764 · Cited by 902
Batty, G. D., Gale, C. R., Kivimäki, M., Deary, I. J., & Bell, S. (2020) · BMJ · doi:10.1136/bmj.m131 · Cited by 635
Metadata
- Authors
- Manolio, T. A., & Collins, R.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-11-24
- Volume
- 304
- Issue
- 20
- Pages
- 2290
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2070185923
- Cited by
- 96
- References
- 2
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhancing the Feasibility of Large Cohort Studies. https://app.cochat.ai/papers/10.1001/jama.2010.1686
- The paper
- Manolio, T. A., & Collins, R. (2010). Enhancing the Feasibility of Large Cohort Studies. JAMA. https://doi.org/10.1001/jama.2010.1686
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.